The CCS is concerned with many aspects of theoretical and computational science, from chemistry and physics to materials, life and biomedical sciences as well as informatics. We explore these domains through high performance, data intensive, supercomputing and distributed (grid/cloud) computing.
Our different computational techniques span time and length-scales from the macro-, through the meso- and to the nano- and microscales. We are committed to studying new approaches and techniques that bridge these scales.
Latest News
Peter Coveney and Miguel Bernabeu's work on Blood Flow Modelling has appeared in an article at New Scientist, you can view the article here.
Peter Coveney made an appearance on the BBC Radio 4 Today show to talk about prosthetic limbs in relation to the Virtual Physiological Human. You can hear his interview at the following link (skip to 54:00 to hear his segment).
The Royal Society have posted a video podcast on the theme issue of Interface Focus "The virtual physiological human: integrative approaches to computational biomedicine", featuring Peter Coveney.
A new theme issue of the Journal of the Royal Society Interface Focus is available online (will be available in print: 6 April 2013). The issue, "The virtual physiological human: integrative approaches to computational biomedicine", was edited by Peter Coveney among others. You can view the theme issue here, it contains selected papers from the VPH2012 conference.
A video on our work in multiscale modelling and simulation has been produced by the MAPPER project on YouTube.
We are pleased to announce the release, under LGPL, of the source code of HemeLB, our high performance fluid dynamics application. HemeLB is optimised for flow at physiologically realistic conditions (such as intracranial arteries) and includes tools for defining simulation domains, visualising the simulation as it runs, and offline post-processing. The source code can be accessed here.
Micha Kunze, Dave Wright, Flemming Hansen, and Peter Coveney have received an NIH (National Institutes of Health) award for the third consecutive year, consisting of a large allocation of cycles on Anton from the DE Shaw Group in New York City, for the period 2012-13. The project will substantially develop and extend research we have underway on the human histone deacetylase 8, extending our investigations from regulation to substrate binding, and complemented using NMR spectroscopy . This enzyme and its family members play an important role in histone post-translational modification, and are thus potential targets for cancer chemotherapeutic agents. For more information, click the link.
